LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

PGC-1β and ERRα Promote Glutamine Metabolism and Colorectal Cancer Survival via Transcriptional Upregulation of PCK2

Photo by nci from unsplash

Previous studies have shown that Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1β (PGC-1β) and Estrogen-Related Receptor alpha (ERRα) are over-expressed in colorectal cancer to promote tumor survival. In this study, we… Click to show full abstract

Previous studies have shown that Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1β (PGC-1β) and Estrogen-Related Receptor alpha (ERRα) are over-expressed in colorectal cancer to promote tumor survival. In this study, we show that amino acid motif LRELL on PGC-1β is responsible for the physical interaction with ERRα and promotes ERRα mRNA and protein expression. Using RNAsequencing, we found that mitochondrial Phosphoenolpyruvate Carboxykinase 2 (PCK2) decreased the most after depletion of both PGC-1β and ERRα. Depletion of PCK2 was sufficient to reduce anchorage-independent growth and inhibit glutamine utilization by the TCA cycle. Lastly, shRNA mediated depletion of ERRα decreased anchorage independent growth and glutamine metabolism, which could not be rescued by plasmid derived expression of PCK2. These findings suggest that transcriptional control of PCK2 is one mechanism used PGC-1β and ERRα to promote glutamine metabolism and colorectal cancer cell survival.

Keywords: glutamine metabolism; pck2; colorectal cancer; pgc err

Journal Title: Cancers
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.